US 6890917
Geldanamycin derivative and method of treating cancer using same
expired A61PA61P35/00A61P43/00
Quick answer
US patent 6890917 (Geldanamycin derivative and method of treating cancer using same) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue May 10 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61P, A61P35/00, A61P43/00